<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Taba">
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td align="left">In December 2019, some cases of viral pneumonia in China were associated with a new coronavirus, which subsequently spread worldwide. WHO has officially named the infection COVID-19, and the virus has been classified as SARS-CoV-2.</td>
   </tr>
   <tr>
    <td align="left">The infection has three worsening clinical pictures: at the onset a mild malaise with symptoms of the upper respiratory tract, subsequently aÂ mild pneumonia, which can later worsen with a picture of acute respiratory distress.</td>
   </tr>
   <tr>
    <td align="left">Early recognition of the clinical picture is essential to be able to start the correct preventive measures and supportive treatments in a short time to avoid possible complications in patients. A combination of public health measures, such as rapid identification, diagnosis and case management, identification and follow-up of contacts, and prevention and control of infections in healthcare facilities, is essential for preventive purposes; also implementation of health measures for travelers, awareness raising in the population and risk communication are important.</td>
   </tr>
   <tr>
    <td align="left">As of March 10, 2020, the number of confirmed cases worldwide was 113,702. According to the ECDC, the CFR for hospitalized COVID-19 cases is 4% and the R0 is estimated between 2 and 3.</td>
   </tr>
   <tr>
    <td align="left">Currently, there are many uncertainties about the origin of the virus, the extent and duration of transmission in humans, the ability to infect other animal hosts and the pathogenesis of human infections. The data collected to date are essential for understanding the threat posed by SARS-CoV-2.</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
